IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events-Reference-Cited by-同舟云学术

IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events

Published:2014-06-19 Issue:2 Volume:29 Page:337-345
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rizzo D,Chauzeix J,Trimoreau F,Woillard J B,Genevieve F,Bouvier A,Labrousse J,Poli C,Guerin E,Dmytruk N,Remenieras L,Feuillard J,Gachard N

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014198.pdf

Reference59 articles.

1. Butler T, Gribben JG . Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia. Blood Rev 2010; 24: 135–141.

2. Rosenquist R, Cortese D, Bhoi S, Mansouri L, Gunnarsson R . Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? Leuk Lymphoma 2013; 54: 2351–2364.

3. Van Bockstaele F, Verhasselt B, Philippé J . Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009; 23: 25–47.

4. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389–1401.

5. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904–6908.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of serum protein electrophoresis with clinicopathological characteristics and its prognostic relevance in chronic lymphocytic leukaemia patients;Journal of the Pakistan Medical Association;2024-03-20

2. Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review;Cancers;2023-09-06

3. Loss of AID exacerbates the malignant progression of CLL;Leukemia;2022-08-30

4. Detection and Characterization of Paraproteinemia in Canine Chronic B‐cell Lymphocytic Leukemia Using Routine and Free Light Chain Immunofixation;Veterinary Clinical Pathology;2022-07-26

5. Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis;Frontiers in Medicine;2022-02-10